Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Buy
644
+391
+155% +$44.3K ﹤0.01% 705
2026
Q1
$288K Buy
+253
New +$29.9K 0.11% 158

Other funds holding ABVX

Persistent Asset Partners's ABVX Position: Q2 2026 in Review

Persistent Asset Partners increased its Abivax (ABVX) stake by 94% in Q2 2026, buying an estimated $2.42M and bringing the position to 44,256 shares worth $5.9M. The position accounts for 1.76% of the portfolio, ranked #10.

Persistent Asset Partners first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Persistent Asset Partners held 44,256 shares of Abivax worth $5.9M as of Q2 2026.
  • Persistent Asset Partners bought 21,418 Abivax shares in Q2 2026, an estimated $2.42M.
  • Abivax made up 1.76% of Persistent Asset Partners's portfolio in Q2 2026, its #10 holding.
  • Persistent Asset Partners first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.